Clinical Trials in Phoenix

Showing 6221-6240 of 12,606 trials

Study of Intravenous Erenumab in Patients With Status Migrainosus

NCT04920331

The investigators will evaluate the efficacy for use of intravenous erenumab 140mg for treatment of status migrainosus in an open-label, pilot study.

Status Migrainosus

Mayo ClinicStarted Sep 2021

Phoenix, Arizona, United States

COMPLETEDPhase 1/2< 1 mile

Dose-Escalation Study of HTX-034 Following Bunionectomy

NCT04398329

This is a Phase 1b/2, randomized, blinded, active-controlled study. Phase 1b will evaluate escalating doses of HTX-034 compared with bupivacaine HCl. Phase 2 will be a dose-expansion phase to evaluate additional subjects treated with the HTX-034 dose selected based on Phase 1b compared with bupivacaine HCl.

Bunions

Heron Therapeutics73 participantsStarted May 2020

Phoenix, Arizona, United States • Bellaire, Texas, United States • San Antonio, Texas, United States +1 more locations

WITHDRAWNPhase 2< 1 mile

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

NCT04982289

This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics (PD), immunogenicity, and efficacy of subcutaneous (SC) ALXN1830 in adults with generalized myasthenia gravis (gMG).

Generalized Myasthenia Gravis

Alexion Pharmaceuticals, Inc.Started Jan 2022

Phoenix, Arizona, United States

COMPLETEDPhase 317 miles

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02636946

This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in participants with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

GlaucomaOpen-Angle Ocular Hypertension

Allergan144 participantsStarted Feb 2016

Dothan, Alabama, United States • Chandler, Arizona, United States • Chandler, Arizona, United States +30 more locations

Study of Intravenous Erenumab in Patients With Status Migrainosus

Dose-Escalation Study of HTX-034 Following Bunionectomy

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Find Trials by Condition in Phoenix

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

X-82 to Treat Age-related Macular Degeneration

PEN-866 in Patients With Advanced Solid Malignancies

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid

Herniorrhaphy Study for Opioid Elimination

Expanded Access Remdesivir (RDV; GS-5734™)

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia